Mural Oncology PLC (MURA)
3.76
+0.04
(+1.08%)
USD |
NASDAQ |
May 01, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Mural Oncology SG&A Expense (Quarterly): 16.27M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.27M |
September 30, 2023 | 5.959M |
Date | Value |
---|---|
December 31, 2022 | 4.969M |
September 30, 2022 | 4.529M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.529M
Minimum
Sep 2022
16.27M
Maximum
Dec 2023
7.932M
Average
5.464M
Median
SG&A Expense (Quarterly) Benchmarks
Amarin Corp PLC | 43.94M |
Jazz Pharmaceuticals PLC | 396.03M |
Prothena Corp PLC | 16.94M |
Iterum Therapeutics PLC | 1.687M |
GH Research PLC | 2.837M |